Akebia Therapeutics Inc (AKBA)
SG&A Expenses
$114.69M
TTM · Period ending: · USD
AKBA SG&A Expenses
Latest reported$114.69Mperiod ending
Latest reported$114.69Mperiod ending
AKBA TTM SG&A Expenses ($5.15M → $114.69M)
TTM SG&A Expenses
High-resolution chart · PNG
AKBA sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 114,686,000 | |
| 113,070,000 | |
| 108,376,000 | |
| 109,962,000 | |
| 106,488,000 | |
| 79,933,000 | |
| 54,191,000 | |
| 51,952,000 | |
| 48,146,000 | |
| 75,182,000 | |
| 100,235,000 | |
| 105,446,000 | |
| 114,623,000 | |
| 119,827,000 | |
| 139,101,000 | |
| 153,258,000 | |
| 167,728,000 | |
| 178,033,000 | |
| 175,034,000 | |
| 170,541,000 | |
| 165,065,000 | |
| 159,046,000 | |
| 156,377,000 | |
| 160,984,000 | |
| 154,281,000 | |
| 154,718,000 | |
| 150,350,000 | |
| 160,553,000 | |
| 136,753,000 | |
| 112,328,000 | |
| 87,061,000 | |
| 39,507,000 | |
| 35,877,000 | |
| 30,244,000 | |
| 27,008,000 | |
| 25,585,000 | |
| 23,781,000 | |
| 22,187,000 | |
| 22,210,000 | |
| 23,577,000 | |
| 22,521,000 | |
| 20,917,000 | |
| 18,497,000 | |
| 14,525,000 | |
| 13,573,000 | |
| 12,181,101 | |
| 12,541,420 | |
| 12,013,041 | |
| 9,871,041 | |
| 8,223,723 | |
| 5,151,327 | |
| 3,438,108 |